Home Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca
 

Keywords :   


Probiodrug Transfers its CDK9 Inhibitor Program to AstraZeneca

2014-01-03 11:53:31| Biotech - Topix.net

Probiodrug AG announced today the transfer of its experimental cyclin-dependent kinase 9 inhibitor program to AstraZeneca .

Tags: program transfers inhibitor astrazeneca

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
15.06Atlantic Tropical Weather Outlook
15.06Eastern North Pacific Tropical Weather Outlook
14.06Bates learned of knighthood at Post Office Inquiry
14.06Chemours Publishes 2023 Sustainability Report
14.06CalPoly Hosts Polymers & Coatings Summer 2024 Short Course
14.06Washington Corner May-June 2024
More »